Imagine constantly navigating life with a motor running too fast, struggling to hit the brakes while everyone else seems to cruise along effortlessly.
This chronic, exhausting imbalance, common for people with Attention-Deficit/Hyperactivity Disorder (ADHD), isn’t just a challenge to focus or stay organized; it carries profound, long-term health consequences.
New research from the UK paints a stark picture of these cumulative impacts.
Key Points
- Adults diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) in the UK have a notably reduced life expectancy compared to the general population.
- The estimated reduction in lifespan is approximately 6.8 years for males and 8.6 years for females.
- The life expectancy deficit is likely driven by modifiable factors, such as smoking, and unmet support needs for ADHD and co-occurring physical and mental health issues.
- People with a diagnosis of ADHD were found to be nearly twice as likely to die during the follow-up period compared to their matched peers.
- The findings highlight an urgent need for better support and services to address health inequalities and improve long-term outcomes for adults with ADHD.
Uncovering the Years of Life Lost
This large-scale, matched cohort study used UK primary care records from 2000–2019 to calculate the life expectancy deficit for adults with a diagnosed ADHD.
By analyzing the records of over 30,000 adults with diagnosed ADHD and 300,000 matched comparison participants, researchers used the life-table method to estimate the average number of years-of-life lost.
It is the first study of its kind globally to use mortality data and the life table method to examine this specific deficit in adults diagnosed with ADHD.
The Size of the Gap
The findings are concerning. The study estimated that an ADHD diagnosis is associated with a significant reduction in life expectancy.
For males with diagnosed ADHD, the estimated total life expectancy was 73.26 years, compared to 80.03 years for comparison males. This represents an estimated loss of 6.78 years of life.
The gap was even wider for females. Females with diagnosed ADHD had an apparent total life expectancy of 75.15 years, compared to 83.79 years for comparison females.
This translates to an estimated loss of 8.64 years of life.
Overall, males with diagnosed ADHD were 1.89 times as likely to die during the follow-up period compared to their comparison group.
For females with a diagnosis, the ratio was even higher at 2.13$ times as likely.
Co-occurring Conditions are Key
Why the difference? The researchers suggest that the reduction in lifespan is likely not due to ADHD itself, but rather to modifiable risk factors and a lack of adequate treatment and support.
The study found that numerous physical and mental health conditions were more common in the ADHD group at the start of the study. This included higher rates of diagnoses for:
- Epilepsy: ADHD males were 3.03 times more likely and ADHD females were 3.49 times more likely to have a diagnosis than their matched peers.
- Severe Mental Illness (SMI): ADHD males were 6.70 times more likely and ADHD females were 8.35 times more likely to have a diagnosis.
- Self-harm/Suicide: ADHD males were 5.80 times more likely and ADHD females were 4.83 times more likely to have a history of self-harm or suicide.
Lifestyle variables also played a significant role. Individuals with ADHD were 2.67 times (males) and 2.15 times (females) more likely to be coded as current smokers.
They also had higher odds of potentially harmful alcohol use. These self-management behaviors, which often include substance use and excess risk-taking, can increase the likelihood of premature death.
The Urgent Need for Better Support
The finding that diagnosed adults are living shorter lives highlights an important inequity.
The authors suggest that the diagnosed population in the study may represent those with higher support needs, as they are the ones who have successfully navigated complex systems to receive a diagnosis.
However, even in this group, support often remains unmet.
Currently, the UK has a scarcity of specialist adult ADHD services, leaving primary care practitioners feeling ill-equipped to meet the needs of their patients.
Why it Matters
The results of this study are a call to action.
They show that ADHD, a neurodevelopmental condition, acts as a gateway to profound health challenges.
The life expectancy deficit is not inevitable; it is a symptom of systemic failures to provide timely, comprehensive support.
Addressing this crisis means:
- Improving Access to Diagnosis and Care: Establishing effective systems and pathways for adult ADHD assessment and treatment.
- Integrating Care: Promoting timely access to support for co-occurring mental and physical health conditions. This includes better awareness and promotion of smoking cessation services.
- Tackling Social Determinants: Focusing on mechanisms like supporting access to employment and preventing discrimination, as socioeconomic status (SES) often mediates the link between ADHD and early mortality. Adults with ADHD are disproportionately likely to experience adversity, including unemployment and financial problems.
By acknowledging and urgently addressing the unmet needs of adults with ADHD, clinicians and policymakers have a clear pathway to closing this significant, but modifiable, life expectancy gap.
Reference
O’nions, E., El Baou, C., John, A., Lewer, D., Mandy, W., McKechnie, D. G., … & Stott, J. (2025). Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study. The British Journal of Psychiatry, 226(5), 261-268. https://doi.org/10.1192/bjp.2024.199